Page 19 - Read Online

proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD. Revenko A, Arun G, Stentrup M, Gross M, Zornig M, MacLeod
RNA 2002;8:1102-11. AR, Spector DL, Diederichs S. The noncoding RNA MALAT1 is a
27. Auboeuf D, Dowhan DH, Li X, Larkin K, Ko L, Berget SM, critical regulator of the metastasis phenotype of lung cancer cells.
O’Malley BW. CoAA, a nuclear receptor coactivator protein at the Cancer Res 2013;73:1180-9.
interface of transcriptional coactivation and RNA splicing. Mol Cell 47. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y,
Biol 2004;24:442-53. Ijiri K, Akimitsu N. MALAT-1 enhances cell motility of lung
28. Fox AH, Bond CS, Lamond AI. P54nrb forms a heterodimer with adenocarcinoma cells by influencing the expression of motility-
PSP1 that localizes to paraspeckles in an RNA-dependent manner. related genes. FEBS Lett 2010;584:4575-80.
Mol Biol Cell 2005;16:5304-15. 48. Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie P, Zhou G, Li G. The
29. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett
AH, Chess A, Lawrence JB. An architectural role for a nuclear 2014;7:2135-41.
noncoding RNA: NEAT1 RNA is essential for the structure of 49. Jiao F, Hu H, Han T, Yuan C, Wang L, Jin Z, Guo Z, Wang L. Long
paraspeckles. Mol Cell 2009;33:717-26. noncoding RNA MALAT-1 enhances stem cell-like phenotypes in
30. Morin GB. The human telomere terminal transferase enzyme pancreatic cancer cells. Int J Mol Sci 2015;16:6677-93.
is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 50. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai
1989;59:521-9. MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li
31. Greider CW, Blackburn EH. A telomeric sequence in the RNA of R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Long
tetrahymena telomerase required for telomere repeat synthesis. non-coding RNA HOTAIR reprograms chromatin state to promote
Nature 1989;337:331-7. cancer metastasis. Nature 2010;464:1071-6.
32. Ly H, Blackburn EH, Parslow TG. Comprehensive structure- 51. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi
function analysis of the core domain of human telomerase RNA. Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold
Mol Cell Biol 2003;23:6849-56. of histone modification complexes. Science 2010;329:689-93.
33. Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between 52. Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Liu T,
aplastic anaemia and mutations in telomerase RNA. Lancet Wang X, Zhou X, Yu J, Hao X. Long non-coding RNA HOTAIR
2002;359:2168-70. promotes tumor cell invasion and metastasis by recruiting EZH2
34. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. and repressing E-cadherin in oral squamous cell carcinoma. Int J
Science 2011;331:1559-64. Oncol 2015;46:2586-94.
35. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi 53. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru
T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, Mori T. H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki Y, Nishida
Expression of E-cadherin cell adhesion molecules in human T, Bamba T, Kanda T, Ajioka Y, Taguchi T, Okahara S, Takahashi H,
breast cancer tissues and its relationship to metastasis. Cancer Res Nishida Y, Hosokawa M, Hasegawa T, Tokino T, Hirata K, Imai K,
1993;53:1696-701. Toyota M, Shinomura Y. Upregulation of miR-196a and HOTAIR drive
36. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier malignant character in gastrointestinal stromal tumors. Cancer Res
W. E-cadherin expression in squamous cell carcinomas of head and 2012;72:1126-36.
neck: inverse correlation with tumor dedifferentiation and lymph 54. Pachnis V, Belayew A, Tilghman SM. Locus unlinked to alpha-
node metastasis. Cancer Res 1991;51:6328-37. fetoprotein under the control of the murine raf and rif genes. Proc
37. Werb Z. ECM and cell surface proteolysis: regulating cellular Natl Acad Sci U S A 1984;81:5523-7.
ecology. Cell 1997;91:439-42. 55. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the
38. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist H19 gene may function as an RNA. Mol Cell Biol 1990;10:28-36.
transcriptionally up-regulates AKT2 in breast cancer cells leading 56. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-
to increased migration, invasion, and resistance to paclitaxel. suppressor activity of H19 RNA. Nature 1993;365:764-7.
Cancer Res 2007;67:1979-87. 57. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K,
39. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth Takagi H. Loss of H19 imprinting in esophageal cancer. Cancer Res
of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72. 1996;56:480-2.
40. Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. 58. Ariel I, Miao HQ, Ji XR, Schneider T, Roll D, de Groot N,
Lancet Oncol 2002;3:425-30. Hochberg A, Ayesh S. Imprinted H19 oncofetal RNA is a candidate
41. Wang H, Fu W, Im JH, Zhou Z, Santoro SA, Iyer V, DiPersio tumour marker for hepatocellular carcinoma. Mol Pathol 1998;51:21-
CM, Yu QC, Quaranta V, Al-Mehdi A, Muschel RJ. Tumor cell 5.
alpha3beta1 integrin and vascular laminin-5 mediate pulmonary 59. Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W,
arrest and metastasis. J Cell Biol 2004;164:935-41. De-Groot N, Hochberg A. Possible physiological role of H19 RNA.
42. Gupta GP, Massague J. Cancer metastasis: building a framework. Mol Carcinog 2002;35:63-74.
Cell 2006;127:679-95. 60. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA
43. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for H19 increases bladder cancer metastasis by associating with EZH2
cancer dormancy. Nat Rev Cancer 2007;7:834-46. and inhibiting E-cadherin expression. Cancer Lett 2013;333:213-
44. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, 21.
Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, 61. Adriaenssens E, Lottin S, Berteaux N, Hornez L, Fauquette W, Fafeur
Serve H, Muller-Tidow C. MALAT-1, a novel noncoding RNA, and V, Peyrat JP, Le Bourhis X, Hondermarck H, Coll J, Dugimont T,
thymosin beta4 predict metastasis and survival in early-stage non- Curgy JJ. Cross-talk between mesenchyme and epithelium increases
small cell lung cancer. Oncogene 2003;22:8031-41. H19 gene expression during scattering and morphogenesis of epithelial
45. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier cells. Exp Cell Res 2002;275:215-29.
SM, Bennett CF, Sharma A, Bubulya PA, Blencowe BJ, Prasanth 62. Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang
SG, Prasanth KV. The nuclear-retained noncoding RNA MALAT1 L, Xiao LJ, Wan DC, Zhang JF, Waye MM. The lncRNA H19
regulates alternative splicing by modulating SR splicing factor promotes epithelial to mesenchymal transition by functioning as
phosphorylation. Mol Cell 2010;39:925-38. miRNA sponges in colorectal cancer. Oncotarget 2015;6:22513-25.
46. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, 63. Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X, Lin L, Yao H, Su F, Li

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ Issue 1 ¦ January 15, 2016 ¦ 9